WATSON 787 25mg (Chlordiazepoxide 25 mg)
Pill imprint WATSON 787 25mg has been identified as Chlordiazepoxide hydrochloride 25 mg.
Chlordiazepoxide is used in the treatment of alcohol withdrawal; anxiety; opiate withdrawal; light sedation; burning mouth syndrome (and more), and belongs to the drug class benzodiazepines. FDA has not classified the drug for risk during pregnancy. Chlordiazepoxide 25 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- WATSON 787 25mg
- Strength:
- 25 mg
- Color:
- Green & White
- Size:
- 4.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Benzodiazepines
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- 4 - Some potential for abuse
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-0787
- Inactive Ingredients:
- lactose anhydrous
microcrystalline cellulose
hydrogenated vegetable oil
gelatin
methylparaben
propylparaben
silicon dioxide
sodium lauryl sulfate
titanium dioxide
More about chlordiazepoxide
Consumer resources
- Other brands: Librium
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
